531 related articles for article (PubMed ID: 1655895)
1. Activation of guinea pig eosinophils by human recombinant IL-5. Selective priming to platelet-activating factor-acether and interference of its antagonists.
Coëffier E; Joseph D; Vargaftig BB
J Immunol; 1991 Oct; 147(8):2595-602. PubMed ID: 1655895
[TBL] [Abstract][Full Text] [Related]
2. LTB4, a potent chemotactic factor for purified guinea-pig eosinophils: interference of PAF-acether antagonists.
Coëffier E; Joseph D; Vargaftig BB
Int J Immunopharmacol; 1991; 13(2-3):273-80. PubMed ID: 1649143
[TBL] [Abstract][Full Text] [Related]
3. Formation of LTB4 by fMLP-stimulated alveolar macrophages accounts for eosinophil migration in vitro.
Hidi R; Coëffier E; Vargaftig BB
J Leukoc Biol; 1992 May; 51(5):425-31. PubMed ID: 1318347
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
Wardlaw AJ; Moqbel R; Cromwell O; Kay AB
J Clin Invest; 1986 Dec; 78(6):1701-6. PubMed ID: 3023451
[TBL] [Abstract][Full Text] [Related]
5. Chemotactic effect of PAF-acether on peritoneal eosinophils from normal rats.
Martins MA; Etienne A; Soulard C; Domingo MT; Braquet P
Braz J Med Biol Res; 1989; 22(9):1151-4. PubMed ID: 2636011
[TBL] [Abstract][Full Text] [Related]
6. Role of interleukin-5 in enhanced migration of eosinophils from airways of immunized guinea-pigs.
Coëffier E; Joseph D; Vargaftig BB
Br J Pharmacol; 1994 Nov; 113(3):749-56. PubMed ID: 7858864
[TBL] [Abstract][Full Text] [Related]
7. Characterization of platelet activating factor (PAF)-acether-induced contractions of guinea-pig lung strips by selected inhibitors of arachidonic acid metabolism and by PAF-acether antagonists.
Touvay C; Vilain B; Etienne A; Sirois P; Borgeat P; Braquet P
Immunopharmacology; 1986 Oct; 12(2):97-104. PubMed ID: 3021651
[TBL] [Abstract][Full Text] [Related]
8. Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects.
Tamura N; Agrawal DK; Suliaman FA; Townley RG
Biochem Biophys Res Commun; 1987 Feb; 142(3):638-44. PubMed ID: 3030295
[TBL] [Abstract][Full Text] [Related]
9. Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig.
Desquand S; Touvay C; Randon J; Lagente V; Vilain B; Maridonneau-Parini I; Etienne A; Lefort J; Braquet P; Vargaftig BB
Eur J Pharmacol; 1986 Aug; 127(1-2):83-95. PubMed ID: 3019727
[TBL] [Abstract][Full Text] [Related]
10. Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists.
Lellouch-Tubiana A; Lefort J; Simon MT; Pfister A; Vargaftig BB
Am Rev Respir Dis; 1988 Apr; 137(4):948-54. PubMed ID: 3281530
[TBL] [Abstract][Full Text] [Related]
11. Eosinophil chemotaxis induced by several biologically active substances and the effects of apafant on it in vitro.
Nabe T; Yamamura H; Kohno S
Arzneimittelforschung; 1997 Oct; 47(10):1112-6. PubMed ID: 9368704
[TBL] [Abstract][Full Text] [Related]
12. Sulochrin inhibits eosinophil activation and chemotaxis.
Ohashi H; Motegi Y; Kita H; Gleich GJ; Miura T; Ishikawa M; Kawai H; Fukamachi H
Inflamm Res; 1998 Oct; 47(10):409-15. PubMed ID: 9831326
[TBL] [Abstract][Full Text] [Related]
13. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
Baroggi N; Etienne A; Braquet P
Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
[TBL] [Abstract][Full Text] [Related]
14. Effects of the platelet activating factor antagonists BN 52021 and BN 50730 on antigen-induced bronchial hyperresponsiveness and eosinophil infiltration in lung from sensitized guinea-pigs.
Lagente V; Boichot E; Carre C; Guinot P; Mencia-Huerta JM; Braquet P
Clin Exp Allergy; 1993 Dec; 23(12):1002-10. PubMed ID: 10779293
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate.
Bruijnzeel PL; Warringa RA; Kok PT; Kreukniet J
Br J Pharmacol; 1990 Apr; 99(4):798-802. PubMed ID: 2163279
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of the PAF receptor antagonist UK-74,505 on neutrophil and eosinophil accumulation in guinea-pig skin.
Sanz MJ; Weg VB; Walsh DT; Williams TJ; Nourshargh S
Br J Pharmacol; 1994 Oct; 113(2):513-21. PubMed ID: 7834203
[TBL] [Abstract][Full Text] [Related]
17. Density heterogeneity of eosinophil leucocytes: induction of hypodense eosinophils by platelet-activating factor.
Yukawa T; Kroegel C; Evans P; Fukuda T; Chung KF; Barnes PJ
Immunology; 1989 Sep; 68(1):140-3. PubMed ID: 2807369
[TBL] [Abstract][Full Text] [Related]
18. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021.
Kurihara K; Wardlaw AJ; Moqbel R; Kay AB
J Allergy Clin Immunol; 1989 Jan; 83(1):83-90. PubMed ID: 2536413
[TBL] [Abstract][Full Text] [Related]
20. Biologic properties of LTB4 and paf-acether in vivo in human skin.
Michel L; Mencia-Huerta JM; Benveniste J; Dubertret L
J Invest Dermatol; 1987 Jun; 88(6):675-81. PubMed ID: 3035030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
